1-(2-bromoethyl)-4-(4-nitrophenyl)piperazine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 1-(2-bromoethyl)-4-(4-nitrophenyl)piperazine
• 化学式: C₁₂H₁₆BrN₃O₂
• 分子量: 314.182
• InChiKey: UIDABFPNFXRJHD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  52.3
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-(2-bromoethyl)-4-(4-nitrophenyl)piperazine 在 铁粉 、 氯化铵 、 N,N-二异丙基乙胺 、 sodium iodide 作用下， 以 乙醇 、 水 、 二甲基亚砜 为溶剂， 反应 3.0h， 生成 tert-butyl (1-(2-(4-(4-aminophenyl)piperazin-1-yl)ethyl)piperidin-4-yl)carbamate
  参考文献：
  名称：

  2,4-DIANILINOPYRIMIDINE-BASED AURORA-A KINASE SELECTIVE DEGRADATION INDUCING COMPOUNDS

  摘要：

  Novel 2,4-Dianilinopyrimidine-based Aurora-A kinase (AURKA) degraders are disclosed. The present AURKA degraders are proteolysis targeting chimeras (PROTACs) that recruit AURKA protein into optimized CRBN E3 ubiquitin ligase via linkers. The compounds may induce selective AURKA degradation and may be utilized for the treatment of cancer.

  公开号：

  WO2024155112A1
• 作为产物：
  描述：

  对氟硝基苯 在 四溴化碳 、 potassium carbonate 、 三苯基膦 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 反应 32.0h， 生成 1-(2-bromoethyl)-4-(4-nitrophenyl)piperazine
  参考文献：
  名称：

  2,4-DIANILINOPYRIMIDINE-BASED AURORA-A KINASE SELECTIVE DEGRADATION INDUCING COMPOUNDS

  摘要：

  Novel 2,4-Dianilinopyrimidine-based Aurora-A kinase (AURKA) degraders are disclosed. The present AURKA degraders are proteolysis targeting chimeras (PROTACs) that recruit AURKA protein into optimized CRBN E3 ubiquitin ligase via linkers. The compounds may induce selective AURKA degradation and may be utilized for the treatment of cancer.

  公开号：

  WO2024155112A1

文献信息

• BMP-SIGNAL-INHIBITING COMPOUND
  申请人：RIKEN

  公开号：US20190337926A1

  公开（公告）日：2019-11-07

  The present invention relates to novel and excellent small-molecule-corn pounds that specifically antagonize BMP signal pathways, and these compounds can be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus can be used to treat diseases or pathological symptoms related to BMP signal pathway including inflammation, cardiovascular diseases, hematopoietic diseases, cancer, osteodystrophia, or the like, particularly, fibrodysplasia ossificans progressiva, and the present invention relates to provision of a pharmaceutical and pharmacological agent used for specifically antagonizing the BMP signal pathways and acting on the BMP signal pathways in the prevention and treatment or experimental application since the compounds can be beneficial for regulating cell differentiation and/or cell proliferation.

  本发明涉及一种新颖且优秀的小分子化合物，可以特异性拮抗BMP信号通路，这些化合物可用于调节细胞生长、分化、增殖和凋亡，因此可用于治疗与BMP信号通路相关的疾病或病理症状，包括炎症、心血管疾病、造血系统疾病、癌症、骨发育不良等，特别是纤维性骨化进行性疾病。本发明涉及提供一种用于特异性拮抗BMP信号通路并作用于BMP信号通路的药物和药理剂，用于预防和治疗或实验应用，因为这些化合物有助于调节细胞分化和/或细胞增殖。
• New derivatives of N-(iminomethy)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
  申请人：SOCIETE DE CONSEILS DE RECHERCHES D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)

  公开号：US20040097494A1

  公开（公告）日：2004-05-20

  N-(imino)amines and their preparation and their use as NO synthase inhibitors and selective or non-selective traps for a reactive oxygen species.

  N-(亚胺基)胺及其制备方法，以及作为NO合酶抑制剂和对反应性氧化物的选择性或非选择性陷阱的用途。
• Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
  申请人：Bigg Dennis

  公开号：US20050197329A1

  公开（公告）日：2005-09-08

  N-(imino)amines and their preparation and their use as NO synthase inhibitors and selective or non-selective traps for a reactive oxygen species.

  N-(亚硝基)胺及其制备方法和用作NO合酶抑制剂和选择性或非选择性捕捉反应性氧化物种的用途。
• New derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
  申请人：Bigg Dennis

  公开号：US20050027009A1

  公开（公告）日：2005-02-03

  N-(imino)amines and their preparation and their use as NO synthase inhibitors and selective or non-selective traps for a reactive oxygen species.

  N-(亚硝基)胺及其制备方法和用途，作为NO合酶抑制剂和选择性或非选择性的反应性氧化物陷阱。
• BMP-signal-inhibiting compound
  申请人：RIKEN

  公开号：US10954216B2

  公开（公告）日：2021-03-23

  The present invention relates to novel and excellent small-molecule-compounds that specifically antagonize BMP signal pathways, and these compounds can be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus can be used to treat diseases or pathological symptoms related to BMP signal pathway including inflammation, cardiovascular diseases, hematopoietic diseases, cancer, osteodystrophia, or the like, particularly, fibrodysplasia ossificans progressiva, and the present invention relates to provision of a pharmaceutical and pharmacological agent used for specifically antagonizing the BMP signal pathways and acting on the BMP signal pathways in the prevention and treatment or experimental application since the compounds can be beneficial for regulating cell differentiation and/or cell proliferation.

  本发明涉及特异性拮抗BMP信号通路的新型优良小分子化合物，这些化合物可用于调节细胞生长、分化、增殖和凋亡，从而可用于治疗与BMP信号通路相关的疾病或病理症状，包括炎症、心血管疾病、造血疾病、癌症、骨营养不良症、本发明涉及提供一种用于特异性拮抗 BMP 信号通路并作用于 BMP 信号通路的药物和药理制剂，以预防和治疗或实验应用，因为该化合物可有益于调节细胞分化和/或细胞增殖。